Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001125282-04-001503
Filing Date
2004-04-07
Accepted
2004-04-07 17:11:25
Documents
6
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F b331125_20f.txt 20-F 496183
3 CERTIFICATIONS b331125ex_1-1.txt EX-1.1 3188
4 CERTIFICATIONS b331125ex_1-2.txt EX-1.2 3203
5 CERTIFICATIONS b331125ex_1-3.txt EX-1.3 1259
6 CERTIFICATIONS b331125ex_1-4.txt EX-1.4 1275
7 CONSENT OF INDEPENDENT AUDITORS b331125ex_23.txt EX-23 750
  Complete submission text file 0001125282-04-001503.txt   508021
Mailing Address 3 ROCK ROAD SANDYFORD INDUSTRIAL ESTATES DUBLIN IRELAND L2 18
Business Address IDA BUSINESS PARK, BRAY, CO WICKLOW IRELAND DUBLIN IRELAND L2 18 01135312955111
TRINITY BIOTECH PLC (Filer) CIK: 0000888721 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-22320 | Film No.: 04722862
SIC: 2835 In Vitro & In Vivo Diagnostic Substances